Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

118.23
Delayed Data
As of Feb 24
 -1.23 / -1.03%
Today’s Change
94.39
Today|||52-Week Range
127.00
+2.14%
Year-to-Date
Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat
Feb 24 / Zacks.com - Paid Partner Content
Here's Why Celgene's Latest Drug Is So Exciting
Feb 23 / MotleyFool.com - Paid Partner Content
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4
Feb 24 / Zacks.com - Paid Partner Content
Go With Allergan, Celgene and 'Big Mo'
Feb 22 / TheStreet.com - Paid Partner Content
BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat
Feb 24 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb 22 / Zacks.com - Paid Partner Content
3 Incredibly Cheap Biotech Stocks
Feb 24 / MotleyFool.com - Paid Partner Content
3 Great Stocks to Buy Instead of NVIDIA Corporation
Feb 21 / MotleyFool.com - Paid Partner Content
Juno Therapeutics (JUNO) Q4 Earnings: What's in the Cards?
Feb 23 / Zacks.com - Paid Partner Content
US exporters line up behind tax code overhaul
Feb 21 / FT.com - Paid Partner Content

Today’s Trading

Previous close119.46
Today’s open118.50
Day’s range117.28 - 119.31
Volume4,485,995
Average volume (3 months)4,697,321
Market cap$92.0B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+21.41%
Earnings growth (next 5 years)+22.37%
Revenue growth (last year)+22.70%
P/E ratio47.5
Price/Sales8.51
Price/Book13.95

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-1.66-0.67%
LLYEli Lilly and Co+0.32+0.39%
BMYBristol-Myers Squibb+0.67+1.20%
ABBVAbbVie+0.15+0.24%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$1.63
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs